DOCSLIB.ORG

“Bridges to the Future”

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
“Bridges to the Future” Abstracts oral and poster presentations 4th Annual Meeting EPIZONE “Bridges to the future” 7-10 June 2010 Saint-Malo, France Hosted by AFSSA Content Welcome ......................................................................................1 Sponsors ......................................................................................5 Keynote Rob Raynard - Infectious Salmon Anaemia: emergence, control and surveillance in Aquaculture .......................11 Theme 4 - Diagnostics – Oral presentations Bernd Hoffman - Identification and characterisation of BTV genome positive single midges using a high throughput system ...........15 Marylène Tignon - African Swine Fever Virus: Interlaboratory validation of a new real-time PCR assay for improved molecular diagnosis ........................................................................16 Ana Ranz - Development of an immunoenzymatic assay based on the double recognition ELISA technique using PRRSV’s n recombinant protein as conjugate and antigen ..............................17 Phil Wakeley - Development of isothermal amplification methods for rapid detection of classical rabies virus ...................................18 Amanda Hanna - Avian Influenza (AI) RNA ring trial testing by real time RT-PCRs and molecular pathotyping ...............................19 Neil LeBlanc - Detection and Subtyping of Influenza A using a Dedicated Suspension Microarray .............................................21 Theme 6 - Surveillance and epidemiology – Oral presentations Nick Knowles - Foot-and-Mouth Disease in the Middle East and Southern Asia: A Continued Threat to Europe................................25 Krzysztof Smietanka - Circulation of closely related low pathogenic AIV H7N7 in mallards in Poland .................................26 I.M.G.A. Santman-Berends - The reproductive performance and the PCR-status of calves of cattle that seroconverted for BTV-8 in the Netherlands in 2008 .......................................................27 Carmen Vela - Development and Assessement of a pen-side test based on the use of VP73 protein for detection of antibodies against ASFV ....................................................................28 Aude Allemandou - Porcine Circovirus (PCV-2) virulence attenuation by mutations in the capsid motif specific of genogroup........29 Irene Greiser-Wilke - Prototype database for storing data of biological agents and their sequences: New developments .................30 Presentation projects GFRA: Cyril Gay ...............................................................33 CSFV_goDIVA: Frank Koenen................................................34 GLaD: Lai-King Ng ............................................................35 Keynote Ken Mc Cullough - Viruses, Vaccines and Dendritic Cells: a question of Life, the Universe and Everything? ...................39 Theme 5 - Intervention strategies – Oral presentations Javier Castillo-Olivares Use of a mouse model to test the vaccination efficacy of recombinant African horse sickness vaccines .........................................................................43 Guenther Keil - Pseudotyping of BacMam recombinants with the G proteins of the rhabdoviruses viral hemorrhagic septicaemia virus and vesicular stomatitis virus to improve gene transfer efficacy into vertebrate cells ...................................................44 Brian Dall - Using small interfering RNAs (siRNAs) to combat a fish pathogenic virus ...........................................................45 Stephan Zientara - Efficacy of two commercial vaccines (BTVPUR ALSAP® 8 (Merial) and BOVILIS® BTV8 (Intervet) against a BTV- 8 virulent challenge in goats...................................................46 Gema Lorenzo - Immunogenicity and protection induced by modified vaccinia virus Ankara (MVA)-based vaccines against Rift Valley fever virus (RVFV) ......................................................48 Rob Moormann.- Paramyxovirus vector vaccines for the control of Rift Valley fever virus........................................................49 Theme 7 - Risk assessment – Oral presentations Fabrizio Natale - Social Network Analysis of livestock movement data for risk assessment and more efficient tracing in case of outbreaks .......................................................................53 Eefke Weesendorp - Risk model for the daily infection probability of classical swine fever via excretions and secretions .......................54 Yves van der Stede - NUSAP method to evaluate assumptions in a Belgian QMRA (METZOON): a link between risk assessment and risk management ...............................................................55 Paul Gale - Potential application of genomic approaches to assist in future risk assessments for the impact of climate change on the host-pathogen-vector interaction .............................................56 Clazien de Vos - Risk of introducing African horse sickness into the Netherlands by importation of equids ....................................57 Lisa Barco - Multivariate analysis to identify potential risk factors for the presence of salmonella in laying hens reared in different housing systems ................................................................58 Presentation projects ConFluTech: Jabbar Ahmed ..................................................61 FLUTRAIN: William Dundon..................................................62 WildTech: Duncan Hannant ..................................................63 Keynote Hana Weingartl - Susceptibility of pigs to Zaire Ebola virus and their potential as an intermediate host species’.........67 Major epidemic threats – Oral presentations Matthijn de Boer - Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge ........................71 Miguel Angel Jimenez-Clavero - Peculiarities of West Nile virus epidemiology in the Western Mediterranean region: wild birds, emerging genotypes and virulence............................................72 Kees van Maanen - Surveillance of West Nile Virus incursions in the Netherlands: validation of antibody detecting ELISAs in Horses .........73 Ana Moreno - Genetic evolution of Italian H1N2 swine influenza viruses during 1998-2009: presence of new reassortant strains ...........74 Enrica Sozzi - Pandemic influenza (A/H1N1) virus in pigs .................75 Angele Breithaupt - Comparative investigations on three duck species infected with clade 1 and clade 2.2 highly pathogenic avian influenza viruses (HPAIV) H5N1 ...............................................76 Carmina Gallardo - African Swine Fever: Are We Ready? .................77 Helena Ferreira - A study on African Swine Fever excretion and survival ..........................................................................78 Taskin Deniz - Optimization of stirred-tank bioreactor operational parameters for batch production processes of BHK 21 an 30 cells in FMD virus production ........................................................79 Gert-Jan Boender - Quantitative analysis of spatial transmission for bluetongue virus serotype 8 in western Europe in 2006.................80 Barbara Tornimbene - Epidemiology of Highly Pathogenic PRRSV in Southern Cambodia: preliminary findings of a field study ................81 Peter Kirkland - Bungowannah virus – a novel pestivirus and recently emerged pathogen. Could it be a major epidemic threat?.........82 Presentation projects ARBO-ZOONET: Jabbar Ahmed· .............................................85 MEDVETNET: André Jestin ...................................................86 Keynote Ian Brown - Threats to animal health from influenza, an EU perspective’ ......................................................89 Keynote Chris Olsen - Swine influenza in North America: virus evolution, control and public health implications’....................93 Poster presentations ..................................................................95 List of participants ...................................................................301 Index .......................................................................................314 Welcome !"#$% O P & O*P 4 "#$% ;;; 4 4 < = > "#$% ; !< 4<&; 4 !< 4@ ; "#$% <* > 4! O ; <<;PO ;J4; 4;4 XP <4; 4 ;4 444 4< < "Y [\\ ;;4[\\ #\"#;4 ] "#$%< ; ";"^"#$% &] ^J"Y`[\\{ ";|`^Y#{ *`[|#{ Y=@`{ [ >|"`[\\{ ; ;^ `#\"#{ |~`Y|{ \4`^Y#{ 4=Y`%#{ ";"`^Y#{ "!`*=Y \|{ "^]4`;^{ ""`Y ^{ "^`#Y#{ !`[{ *`#"{ Sponsors HUMAN CARE FOR ANIMAL KIND © Christophe Beauregard - © Getty Images © Christophe Beauregard We constantly strive to care for animals because they are what matters to you. By offering best-in-class products we deliver quality solutions from prevention to treatment, across therapeutic areas, for horses and all other species. With high value added services and technical support we earn the trust of veterinary surgeons, farmers and pet-owners. From animal health to animal well-being, we aim to be your preferred partner everyday. Building a new Pfizer Animal Health. Anticipating market changes. Meeting your needs. Our commitment, a new era of partnership. Human Care for Animal Kind. Welcome to Zulvacuum 7ZegZeVgZYl^i]OjakVX"WajZidc\jZ hZgdineZ-kVXX^cZh[dgXViiaZVcYh]ZZe# Zulvac 8 Bovis and now the new Zulvac 8 Ovis provide a cost effective option for protecting your animals from bluetongue. ® Ovis Use both products as a single shot booster
Load more

Recommended publications
  • LES PESTIVIRUS À L'interface FAUNE SAUVAGE/FAUNE DOMESTIQUE : Pathogénie Chez L'isard Gestant Et Épidémiologie Dans La
    THESE Présentée devant L’UNIVERSITE DE NICE SOPHIA ANTIPOLIS EN COTUTELLE AVEC L’UNIVERSITE DE LIEGE pour l’obtention du DIPLOME DE DOCTORAT (arrêté du 25 avril 2002) Spécialité INTERACTIONS MOLECULAIRES Et du DIPLOME EN SCIENCES VETERINAIRES présentée et soutenue publiquement le 20 décembre 2011 par Mlle Claire MARTIN LES PESTIVIRUS À L’INTERFACE FAUNE SAUVAGE/FAUNE DOMESTIQUE : Pathogénie chez l’isard gestant et épidémiologie dans la région Provence-Alpes-Côte D’azur JURY : M. Richard THIERY, co-directeur de thèse M. Claude SAEGERMAN, co-directeur de thèse Mme Anny CUPO, co-directeur de thèse Mme Sophie ROSSI, Examinateur M. François MOUTOU, Examinateur M. Benoît DURAND, Rapporteur Mme Marie-Pierre RYSER-GEGIORGIS, Rapporteur M. Pascal HENDRIKS, Président de jury 1 2 RESUME Dans les Alpes du Sud de la France, des diminutions de populations de chamois (Rupicapra rupicapra) ont été rapportées. Or, depuis une dizaine d’année, des pestivirus ont causé de fortes mortalités dans des populations d’isards des Pyrénées (Rupicapra pyrenaica). Bien que les signes cliniques associés à cette infection aient été caractérisés chez cette espèce, la pathogénie chez les animaux gestants est peu étudiée. De plus, des transmissions inter-espèces ont régulièrement été incriminées dans l’épidémiologie des pestiviroses ; ceci particulièrement au niveau des alpages où des contacts fréquents sont décrits entre ruminants sauvages et domestiques. Les objectifs de ce travail de thèse ont donc été, dans un premier temps, d’étudier la pathogénie de l’infection à pestivirus chez des isards et plus particulièrement ses effets sur la gestation. Dans un second temps, nous avons étudié l’épidémiologie de l’infection dans différentes zones de la région Provence-Alpes-Côte d’Azur (PACA), tout d’abord chez des ruminants sauvages, puis à l’interface entre les ruminants sauvages et domestiques partageant les mêmes alpages.
    [Show full text]
  • 2020 Taxonomic Update for Phylum Negarnaviricota (Riboviria: Orthornavirae), Including the Large Orders Bunyavirales and Mononegavirales
    Archives of Virology https://doi.org/10.1007/s00705-020-04731-2 VIROLOGY DIVISION NEWS 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales Jens H. Kuhn1 · Scott Adkins2 · Daniela Alioto3 · Sergey V. Alkhovsky4 · Gaya K. Amarasinghe5 · Simon J. Anthony6,7 · Tatjana Avšič‑Županc8 · María A. Ayllón9,10 · Justin Bahl11 · Anne Balkema‑Buschmann12 · Matthew J. Ballinger13 · Tomáš Bartonička14 · Christopher Basler15 · Sina Bavari16 · Martin Beer17 · Dennis A. Bente18 · Éric Bergeron19 · Brian H. Bird20 · Carol Blair21 · Kim R. Blasdell22 · Steven B. Bradfute23 · Rachel Breyta24 · Thomas Briese25 · Paul A. Brown26 · Ursula J. Buchholz27 · Michael J. Buchmeier28 · Alexander Bukreyev18,29 · Felicity Burt30 · Nihal Buzkan31 · Charles H. Calisher32 · Mengji Cao33,34 · Inmaculada Casas35 · John Chamberlain36 · Kartik Chandran37 · Rémi N. Charrel38 · Biao Chen39 · Michela Chiumenti40 · Il‑Ryong Choi41 · J. Christopher S. Clegg42 · Ian Crozier43 · John V. da Graça44 · Elena Dal Bó45 · Alberto M. R. Dávila46 · Juan Carlos de la Torre47 · Xavier de Lamballerie38 · Rik L. de Swart48 · Patrick L. Di Bello49 · Nicholas Di Paola50 · Francesco Di Serio40 · Ralf G. Dietzgen51 · Michele Digiaro52 · Valerian V. Dolja53 · Olga Dolnik54 · Michael A. Drebot55 · Jan Felix Drexler56 · Ralf Dürrwald57 · Lucie Dufkova58 · William G. Dundon59 · W. Paul Duprex60 · John M. Dye50 · Andrew J. Easton61 · Hideki Ebihara62 · Toufc Elbeaino63 · Koray Ergünay64 · Jorlan Fernandes195 · Anthony R. Fooks65 · Pierre B. H. Formenty66 · Leonie F. Forth17 · Ron A. M. Fouchier48 · Juliana Freitas‑Astúa67 · Selma Gago‑Zachert68,69 · George Fú Gāo70 · María Laura García71 · Adolfo García‑Sastre72 · Aura R. Garrison50 · Aiah Gbakima73 · Tracey Goldstein74 · Jean‑Paul J. Gonzalez75,76 · Anthony Grifths77 · Martin H. Groschup12 · Stephan Günther78 · Alexandro Guterres195 · Roy A.
    [Show full text]
  • Influence of Border Disease Virus (BDV) on Serological Surveillance Within the Bovine Virus Diarrhea (BVD) Eradication Program in Switzerland V
    Kaiser et al. BMC Veterinary Research (2017) 13:21 DOI 10.1186/s12917-016-0932-0 RESEARCH ARTICLE Open Access Influence of border disease virus (BDV) on serological surveillance within the bovine virus diarrhea (BVD) eradication program in Switzerland V. Kaiser1, L. Nebel1, G. Schüpbach-Regula2, R. G. Zanoni1* and M. Schweizer1* Abstract Background: In 2008, a program to eradicate bovine virus diarrhea (BVD) in cattle in Switzerland was initiated. After targeted elimination of persistently infected animals that represent the main virus reservoir, the absence of BVD is surveilled serologically since 2012. In view of steadily decreasing pestivirus seroprevalence in the cattle population, the susceptibility for (re-) infection by border disease (BD) virus mainly from small ruminants increases. Due to serological cross-reactivity of pestiviruses, serological surveillance of BVD by ELISA does not distinguish between BVD and BD virus as source of infection. Results: In this work the cross-serum neutralisation test (SNT) procedure was adapted to the epidemiological situation in Switzerland by the use of three pestiviruses, i.e., strains representing the subgenotype BVDV-1a, BVDV-1h and BDSwiss-a, for adequate differentiation between BVDV and BDV. Thereby the BDV-seroprevalence in seropositive cattle in Switzerland was determined for the first time. Out of 1,555 seropositive blood samples taken from cattle in the frame of the surveillance program, a total of 104 samples (6.7%) reacted with significantly higher titers against BDV than BVDV. These samples originated from 65 farms and encompassed 15 different cantons with the highest BDV-seroprevalence found in Central Switzerland. On the base of epidemiological information collected by questionnaire in case- and control farms, common housing of cattle and sheep was identified as the most significant risk factor for BDV infection in cattle by logistic regression.
    [Show full text]
  • Molecular and Serological Survey of Selected Viruses in Free-Ranging Wild Ruminants in Iran
    RESEARCH ARTICLE Molecular and Serological Survey of Selected Viruses in Free-Ranging Wild Ruminants in Iran Farhid Hemmatzadeh1*, Wayne Boardman1,2, Arezo Alinejad3, Azar Hematzade4, Majid Kharazian Moghadam5 1 School of Animal and Veterinary Sciences, The University of Adelaide, Adelaide, Australia, 2 School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia, 3 DVM graduate, Faculty a1111111111 of Veterinary Medicine, The University of Tehran, Tehran, Iran, 4 Faculty of Agriculture, Islamic Azad a1111111111 University, Shahrekord branch, Shahrekord, Iran, 5 Iran Department of Environment, Tehran, Iran a1111111111 a1111111111 * [email protected] a1111111111 Abstract A molecular and serological survey of selected viruses in free-ranging wild ruminants was OPEN ACCESS conducted in 13 different districts in Iran. Samples were collected from 64 small wild rumi- Citation: Hemmatzadeh F, Boardman W, Alinejad nants belonging to four different species including 25 Mouflon (Ovis orientalis), 22 wild goat A, Hematzade A, Moghadam MK (2016) Molecular (Capra aegagrus), nine Indian gazelle (Gazella bennettii) and eight Goitered gazelle and Serological Survey of Selected Viruses in Free- (Gazella subgutturosa) during the national survey for wildlife diseases in Iran. Serum sam- Ranging Wild Ruminants in Iran. PLoS ONE 11 (12): e0168756. doi:10.1371/journal. ples were evaluated using serologic antibody tests for Peste de petits ruminants virus pone.0168756 (PPRV), Pestiviruses [Border Disease virus (BVD) and Bovine Viral Diarrhoea virus Editor: Graciela Andrei, Katholieke Universiteit (BVDV)], Bluetongue virus (BTV), Bovine herpesvirus type 1 (BHV-1), and Parainfluenza Leuven Rega Institute for Medical Research, type 3 (PI3). Sera were also ELISA tested for Pestivirus antigen.
    [Show full text]
  • International Requisition Form
    PleasePlease place place collection collection kit kit INTERNATIONAL barcode here. REQUISITION FORM barcode here. REQUISITION FORM 123456-2-X PLEASE COMPLETE ALL FIELDS. REQUISITION FORMS SUBMITTED WITH MISSING INFORMATION MAY CAUSE A DELAY IN TURNAROUND TIME OF THE TEST. PLEASE COMPLETE ALL FIELDS. REQUISITION FORMS SUBMITTED WITH MISSING INFORMATION MAY CAUSE A DELAY IN TURNAROUND TIME OF THE TEST. PATIENT INFORMATION ORDERING CLINICIAN INFORMATION PATIENT NAME (LAST, FIRST) NAME OF ORGANIZATION 1 PatIENT INFORmatION (Must be completed in English) 2 ORDERING CLINICIAN (Must be completed in English) DATE OF BIRTH (MM/DD/YYYY) Organization (Clinic, Hospital, or Lab): Patient Name (Last, First): ADDRESS TELEPHONE CITYPatient DOB (DD/MM/YYYY): STATE ZIP CODE ORDERINGLIMS-ID: CLINICIAN TELEPHONE EMAIL Patient Street Address: Telephone: I would like to receive emails about my test from Natera Y N City: Country: Ordering Clinician: PATIENT MALE OR FEMALE? M-V26.34 F-V26.31 PATIENT PREGNANT? Y-V22.1 N DATE OF SAMPLE COLLECTION (MM/DD/YY):_____________________________ Telephone: Email: PAYMENT PLEASEPatient CHECK male orONE: female: M F BILL INSURANCE BILL CLINIC BILL CLINIC/CA Prenatal SELF-PAY Patient pregnant? Program YPDC N INSURANCE COMPANY (Please enclose a photocopy (front and CLINICIAN INFORMED CONSENT MEMBERDate of ID sample collectionSUBSCRIBER (DD/MM/YYYY): NAME (if different than patient) back) or all relevant insurance cards) If you would like the results of this case to be sent to an additional FAX fax number other than what is indicated on your setup form, please IF SELF-PAY, CHECK CARD TYPE: VISA MASTER CARD AMEX DISCOVER provide the fax number.
    [Show full text]
  • Bat Rabies and Other Lyssavirus Infections
    Prepared by the USGS National Wildlife Health Center Bat Rabies and Other Lyssavirus Infections Circular 1329 U.S. Department of the Interior U.S. Geological Survey Front cover photo (D.G. Constantine) A Townsend’s big-eared bat. Bat Rabies and Other Lyssavirus Infections By Denny G. Constantine Edited by David S. Blehert Circular 1329 U.S. Department of the Interior U.S. Geological Survey U.S. Department of the Interior KEN SALAZAR, Secretary U.S. Geological Survey Suzette M. Kimball, Acting Director U.S. Geological Survey, Reston, Virginia: 2009 For more information on the USGS—the Federal source for science about the Earth, its natural and living resources, natural hazards, and the environment, visit http://www.usgs.gov or call 1–888–ASK–USGS For an overview of USGS information products, including maps, imagery, and publications, visit http://www.usgs.gov/pubprod To order this and other USGS information products, visit http://store.usgs.gov Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. Government. Although this report is in the public domain, permission must be secured from the individual copyright owners to reproduce any copyrighted materials contained within this report. Suggested citation: Constantine, D.G., 2009, Bat rabies and other lyssavirus infections: Reston, Va., U.S. Geological Survey Circular 1329, 68 p. Library of Congress Cataloging-in-Publication Data Constantine, Denny G., 1925– Bat rabies and other lyssavirus infections / by Denny G. Constantine. p. cm. - - (Geological circular ; 1329) ISBN 978–1–4113–2259–2 1.
    [Show full text]
  • European Conference on Rare Diseases
    EUROPEAN CONFERENCE ON RARE DISEASES Luxembourg 21-22 June 2005 EUROPEAN CONFERENCE ON RARE DISEASES Copyright 2005 © Eurordis For more information: www.eurordis.org Webcast of the conference and abstracts: www.rare-luxembourg2005.org TABLE OF CONTENT_3 ------------------------------------------------- ACKNOWLEDGEMENTS AND CREDITS A specialised clinic for Rare Diseases : the RD TABLE OF CONTENTS Outpatient’s Clinic (RDOC) in Italy …………… 48 ------------------------------------------------- ------------------------------------------------- 4 / RARE, BUT EXISTING The organisers particularly wish to thank ACKNOWLEDGEMENTS AND CREDITS 4.1 No code, no name, no existence …………… 49 ------------------------------------------------- the following persons/organisations/companies 4.2 Why do we need to code rare diseases? … 50 PROGRAMME COMMITTEE for their role : ------------------------------------------------- Members of the Programme Committee ……… 6 5 / RESEARCH AND CARE Conference Programme …………………………… 7 …… HER ROYAL HIGHNESS THE GRAND DUCHESS OF LUXEMBOURG Key features of the conference …………………… 12 5.1 Research for Rare Diseases in the EU 54 • Participants ……………………………………… 12 5.2 Fighting the fragmentation of research …… 55 A multi-disciplinary approach ………………… 55 THE EUROPEAN COMMISSION Funding of the conference ……………………… 14 Transfer of academic research towards • ------------------------------------------------- industrial development ………………………… 60 THE GOVERNEMENT OF LUXEMBOURG Speakers ……………………………………………… 16 Strengthening cooperation between academia
    [Show full text]
  • NGS Sequencing May Be Wes Or Targeted
    Guidelines for diagnostic next generation sequencing 2 December 2014 LS, This is the final draft version of a document on the diagnostic use of NGS that we wish to publish on behalf of EuroGentest. The first version of this document was drafted by a small number of people. It was subjected to peer review by the participants to the Nijmegen meeting, November 21-22, 2013. The document is ready for circulation and public consultation. Hence, it will be posted on the EuroGentest website for a few weeks. The procedure is in line with the process that other policy documents, generated by the European Society of Human Genetics, have to follow: the background document is posted and an invitation to comment is sent to the membership of the Society. Thereafter, a final version of the guidelines will be published in the European Journal for Human Genetics. Of course, guidelines in a fast moving field can never be definitive, hence a system will be put in place to update them on a regular basis. I wish to thank all the colleagues who have contributed to the development of the guidelines and the generation of the document. The members of the working group will be co-authors on the paper, the contribution of the other participants to the Nijmegen meeting will be acknowledged. We believe that the document is timely, even though we have been slow in finalizing the editorial work. By posting it now, everybody who is interested in the guidelines or eagerly seeking advice will be able to consult the workgroup’s viewpoints and recommendations.
    [Show full text]
  • Environmental Nutrition: Redefining Healthy Food
    Environmental Nutrition Redefining Healthy Food in the Health Care Sector ABSTRACT Healthy food cannot be defined by nutritional quality alone. It is the end result of a food system that conserves and renews natural resources, advances social justice and animal welfare, builds community wealth, and fulfills the food and nutrition needs of all eaters now and into the future. This paper presents scientific data supporting this environmental nutrition approach, which expands the definition of healthy food beyond measurable food components such as calories, vitamins, and fats, to include the public health impacts of social, economic, and environmental factors related to the entire food system. Adopting this broader understanding of what is needed to make healthy food shifts our focus from personal responsibility for eating a healthy diet to our collective social responsibility for creating a healthy, sustainable food system. We examine two important nutrition issues, obesity and meat consumption, to illustrate why the production of food is equally as important to consider in conversations about nutrition as the consumption of food. The health care sector has the opportunity to harness its expertise and purchasing power to put an environmental nutrition approach into action and to make food a fundamental part of prevention-based health care. but that it must come from a food system that conserves and I. Using an Environmental renews natural resources, advances social justice and animal welfare, builds community wealth, and fulfills the food and Nutrition Approach to nutrition needs of all eaters now and into the future.i Define Healthy Food This definition of healthy food can be understood as an environmental nutrition approach.
    [Show full text]
  • Characterization of One Sheep Border Disease Virus in China Li Mao1,2, Xia Liu1,2, Wenliang Li1,2, Leilei Yang1,2, Wenwen Zhang1,2 and Jieyuan Jiang1,2*
    Mao et al. Virology Journal (2015) 12:15 DOI 10.1186/s12985-014-0217-9 RESEARCH Open Access Characterization of one sheep border disease virus in China Li Mao1,2, Xia Liu1,2, Wenliang Li1,2, Leilei Yang1,2, Wenwen Zhang1,2 and Jieyuan Jiang1,2* Abstract Background: Border disease virus (BDV) causes border disease (BD) affecting mainly sheep and goats worldwide. BDV in goat herds suffering diarrhea was recently reported in China, however, infection in sheep was undetermined. Here, BDV infections of sheep herds in Jiangsu, China were screened; a BDV strain was isolated and identified from the sheep flocks in China. The genomic characteristics and pathogenesis of this new isolate were studied. Results: In 2012, samples from 160 animals in 5 regions of Jiangsu province of China were screened for the presence of BDV genomic RNA and antibody by RT-PCR and ELISA, respectively. 44.4% of the sera were detected positively, and one slowly grown sheep was analyzed to be pestivirus RNA positive and antibody-negative. The sheep kept virus positive and antibody negative in the next 6 months of whole fattening period, and was defined as persistent infection (PI). The virus was isolated in MDBK cells without cytopathic effect (CPE) and named as JSLS12-01. Near-full-length genome sequenced was 12,227 nucleotides (nt). Phylogenetic analysis based on 5'-UTR and Npro fragments showed that the strain belonged to genotype 3, and shared varied homology with the other 3 BDV strains previously isolated from Chinese goats. The genome sequence of JSLS12-01 also had the highest homology with genotype BDV-3 (the strain Gifhorn).
    [Show full text]
  • Regulations for Disease Reporting and Control
    Department of Health Regulations for Disease Reporting and Control Commonwealth of Virginia State Board of Health October 2016 Virginia Department of Health Office of Epidemiology 109 Governor Street P.O. Box 2448 Richmond, VA 23218 Department of Health Department of Health TABLE OF CONTENTS Part I. DEFINITIONS ......................................................................................................................... 1 12 VAC 5-90-10. Definitions ............................................................................................. 1 Part II. GENERAL INFORMATION ............................................................................................... 8 12 VAC 5-90-20. Authority ............................................................................................... 8 12 VAC 5-90-30. Purpose .................................................................................................. 8 12 VAC 5-90-40. Administration ....................................................................................... 8 12 VAC 5-90-70. Powers and Procedures of Chapter Not Exclusive ................................ 9 Part III. REPORTING OF DISEASE ............................................................................................. 10 12 VAC 5-90-80. Reportable Disease List ....................................................................... 10 A. Reportable disease list ......................................................................................... 10 B. Conditions reportable by directors of
    [Show full text]
  • ICD-10 International Statistical Classification of Diseases and Related Health Problems
    ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Volume 2 Instruction manual 2010 Edition WHO Library Cataloguing-in-Publication Data International statistical classification of diseases and related health problems. - 10th revision, edition 2010. 3 v. Contents: v. 1. Tabular list – v. 2. Instruction manual – v. 3. Alphabetical index. 1.Diseases - classification. 2.Classification. 3.Manuals. I.World Health Organization. II.ICD-10. ISBN 978 92 4 154834 2 (NLM classification: WB 15) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]